|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
027389626 |
| 003 |
DE-627 |
| 005 |
20230905075231.0 |
| 007 |
tu |
| 008 |
710101s1984 xxk||||| 00| ||eng c |
| 016 |
7 |
|
|a b8424038
|2 UK
|
| 020 |
|
|
|a 0710200498
|9 0-7102-0049-8
|
| 024 |
8 |
|
|a 83011149
|q Identnummer
|
| 035 |
|
|
|a (DE-627)027389626
|
| 035 |
|
|
|a (DE-576)020661584
|
| 035 |
|
|
|a (DE-599)GBV027389626
|
| 035 |
|
|
|a (OCoLC)9643167
|
| 035 |
|
|
|a (OCoLC)230572542
|
| 035 |
|
|
|a (OCoLC)09643167
|
| 035 |
|
|
|a (DE-604)8034439196
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-GB
|
| 050 |
|
0 |
|a HV6769
|
| 050 |
|
0 |
|a HD9665.5
|
| 060 |
|
0 |
|a QV 773 B814c
|
| 082 |
0 |
|
|a 364.1/68
|q LOC
|2 19
|
| 082 |
0 |
|
|a 338.4'76151
|
| 084 |
|
|
|a 2
|2 ssgn
|
| 084 |
|
|
|a QC 010
|2 rvk
|0 (DE-625)rvk/141236:
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 084 |
|
|
|a 83.67
|2 bkl
|
| 100 |
1 |
|
|a Braithwaite, John
|d 1951-
|0 (DE-588)131504258
|0 (DE-627)51015445X
|0 (DE-576)160400392
|4 aut
|
| 109 |
|
|
|a Braithwaite, John 1951-
|a Braithwaite, John B. 1951-
|a Braithwaite, John Bradford 1951-
|a Bradford Braithwaite, John 1951-
|a Braithwait, John 1951-
|
| 245 |
1 |
0 |
|a Corporate crime in the pharmaceutical industry
|c John Braithwaite
|
| 264 |
|
1 |
|a London [u.a.]
|b Routledge & Kegan Paul
|c 1984
|
| 300 |
|
|
|a VIII, 440 S
|c 8°
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Bibliography: p 408-427. - Includes index
|
| 650 |
|
0 |
|a Commercial crimes
|v Case studies
|
| 650 |
|
0 |
|a Corporations
|x Corrupt practices
|v Case studies
|
| 650 |
|
0 |
|a Pharmaceutical Industry
|x Corrupt practices
|z United States
|v Case studies
|
| 650 |
|
0 |
|a Professional Ethics
|
| 650 |
|
0 |
|a White collar crimes
|
| 650 |
|
2 |
|a Drug Industry
|x Standards
|
| 650 |
|
2 |
|a Crime
|
| 650 |
|
4 |
|a Pharmaceutical industries. Corruption
|
| 689 |
0 |
0 |
|d s
|0 (DE-588)4045696-1
|0 (DE-627)106200690
|0 (DE-576)209066393
|a Pharmazeutische Industrie
|2 gnd
|
| 689 |
0 |
1 |
|d s
|0 (DE-588)4066464-8
|0 (DE-627)106113437
|0 (DE-576)209164719
|a Wirtschaftskriminalität
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/027389626.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 889 |
|
|
|w (DE-627)43295645X
|
| 935 |
|
|
|i mdedup
|
| 935 |
|
|
|i Blocktest
|
| 936 |
r |
v |
|a QC 010
|b Mensch und Wirtschaft. Wirtschaftliches Verhalten. Motivation. Wirtschaftsethik
|k Wirtschaftstheorie, einschließlich Geldtheorie
|k Mensch und Wirtschaft. Wirtschaftliches Verhalten. Motivation. Wirtschaftsethik
|0 (DE-627)1271174472
|0 (DE-625)rvk/141236:
|0 (DE-576)201174472
|
| 936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|0 (DE-627)106423304
|
| 936 |
b |
k |
|a 83.67
|j Produzierendes Gewerbe
|0 (DE-627)106418068
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 3339302324
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 027389626
|
| LOK |
|
|
|0 005 20020606000000
|
| LOK |
|
|
|0 008 900608||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 15 A 924
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| LOK |
|
|
|0 936ln
|a k9.7.2.1
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 15 A 924
|
